CJ Bioscience, Inc. (KOSDAQ:311690)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,030.00
-30.00 (-0.37%)
At close: Mar 6, 2026

CJ Bioscience Revenue

CJ Bioscience had revenue of 737.90M KRW in the quarter ending September 30, 2025, a decrease of -0.85%. This brings the company's revenue in the last twelve months to 3.38B, down -14.90% year-over-year. In the year 2024, CJ Bioscience had annual revenue of 3.47B, down -37.82%.

Revenue (ttm)
3.38B
Revenue Growth
-14.90%
P/S Ratio
29.96
Revenue / Employee
n/a
Employees
n/a
Market Cap
101.13B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20243.47B-2.11B-37.82%
Dec 31, 20235.58B1.50B36.82%
Dec 31, 20224.07B-288.37M-6.61%
Dec 31, 20214.36B-948.52M-17.86%
Dec 31, 20205.31B528.32M11.05%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Maum.AI 8.33B
Korea Computer & Systems 24.37B
KT Genie Music 299.72B
DEEPNOID 9.45B
PonyLink 43.13B
OPASNET co. 221.69B
SPSoft 56.89B
WINS Technet 95.91B
Revenue Rankings